| Naturally occurring antibodies devoid of light chains C Hamers-Casterman, T Atarhouch, S Muyldermans, G Robinson, ... Nature 363 (6428), 446-448, 1993 | 3661 | 1993 |
| Nanobodies: natural single-domain antibodies S Muyldermans Annual review of biochemistry 82, 775-797, 2013 | 1916 | 2013 |
| Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies M Arbabi Ghahroudi, A Desmyter, L Wyns, R Hamers, S Muyldermans FEBS letters 414 (3), 521-526, 1997 | 1049 | 1997 |
| Single domain camel antibodies: current status S Muyldermans Reviews in molecular Biotechnology 74 (4), 277-302, 2001 | 1018 | 2001 |
| Single‐domain antibody fragments with high conformational stability M Dumoulin, K Conrath, A Van Meirhaeghe, F Meersman, K Heremans, ... Protein Science 11 (3), 500-515, 2002 | 749 | 2002 |
| A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins U Rothbauer, K Zolghadr, S Muyldermans, A Schepers, MC Cardoso, ... Molecular & Cellular Proteomics 7 (2), 282-289, 2008 | 745 | 2008 |
| Targeting and tracing antigens in live cells with fluorescent nanobodies U Rothbauer, K Zolghadr, S Tillib, D Nowak, L Schermelleh, A Gahl, ... Nature methods 3 (11), 887-889, 2006 | 730 | 2006 |
| Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies E De Genst, K Silence, K Decanniere, K Conrath, R Loris, J Kinne, ... Proceedings of the National Academy of Sciences 103 (12), 4586-4591, 2006 | 711 | 2006 |
| Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains S Muyldermans, T Atarhouch, J Saldanha, J Barbosa, R Hamers Protein Engineering, Design and Selection 7 (9), 1129-1135, 1994 | 711 | 1994 |
| Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme A Desmyter, TR Transue, MA Ghahroudi, MH Dao Thi, F Poortmans, ... Nature structural biology 3 (9), 803-811, 1996 | 681 | 1996 |
| A general protocol for the generation of Nanobodies for structural biology E Pardon, T Laeremans, S Triest, SGF Rasmussen, A Wohlkönig, A Ruf, ... Nature protocols 9 (3), 674-693, 2014 | 639 | 2014 |
| Potent enzyme inhibitors derived from dromedary heavy-chain antibodies M Lauwereys, MA Ghahroudi, A Desmyter, J Kinne, W Hölzer, E De Genst, ... The EMBO journal 17 (13), 3512-3520, 1998 | 638 | 1998 |
| Camelid immunoglobulins and nanobody technology S Muyldermans, TN Baral, VC Retamozzo, P De Baetselier, E De Genst, ... Veterinary immunology and immunopathology 128 (1-3), 178-183, 2009 | 590 | 2009 |
| General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold C Vincke, R Loris, D Saerens, S Martinez-Rodriguez, S Muyldermans, ... Journal of Biological Chemistry 284 (5), 3273-3284, 2009 | 565 | 2009 |
| Modulation of protein properties in living cells using nanobodies A Kirchhofer, J Helma, K Schmidthals, C Frauer, S Cui, A Karcher, ... Nature structural & molecular biology 17 (1), 133-138, 2010 | 561 | 2010 |
| Efficient cancer therapy with a nanobody-based conjugate V Cortez-Retamozo, N Backmann, PD Senter, U Wernery, P De Baetselier, ... Cancer research 64 (8), 2853-2857, 2004 | 506 | 2004 |
| Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains S Muyldermans, C Cambillau, L Wyns Trends in biochemical sciences 26 (4), 230-235, 2001 | 453 | 2001 |
| Comparison of llama VH sequences from conventional and heavy chain antibodies KB Vu, MA Ghahroudi, L Wyns, S Muyldermans Molecular immunology 34 (16-17), 1121-1131, 1997 | 435 | 1997 |
| The therapeutic potential of nanobodies I Jovčevska, S Muyldermans BioDrugs 34 (1), 11-26, 2020 | 433 | 2020 |
| β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae KE Conrath, M Lauwereys, M Galleni, A Matagne, JM Frère, J Kinne, ... Antimicrobial agents and chemotherapy 45 (10), 2807-2812, 2001 | 427 | 2001 |
